Tricida, Inc. (TCDA) Social Stream
TRICIDA INC (TCDA) Price Targets From Analysts
Use the tables below to see what analysts covering TRICIDA INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 29 months, TCDA's average price target has gone down $36.
TCDA reports an average of 79.81% for its upside potential over the past 45 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TCDA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 43 weeks, TCDA's average broker recommendation rating improved by 0.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how TRICIDA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 47.96% of that group.
- To contextualize these metrics, consider that out of all US stocks, TRICIDA INC's variance in analysts' estimates is lower than -333.77% of them.
- In the context of Pharmaceutical Products stocks, TRICIDA INC's upside potential (average analyst target price relative to current price) is greater than 138.48% of them.
- TCDA has a greater average analyst price target than 174.38% of Healthcare stocks.
What is the outlook for TCDA? Use POWR Ratings for clearer insight into price direction.